Page last updated: 2024-08-23

dobutamine and cromakalim

dobutamine has been researched along with cromakalim in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lavallée, M; Okajima, M; Parent, R; Thorin, E	1

Other Studies

1 other study(ies) available for dobutamine and cromakalim

Article	Year
Pathophysiological plasma ET-1 levels antagonize beta-adrenergic dilation of coronary resistance vessels in conscious dogs. American journal of physiology. Heart and circulatory physiology, 2004, Volume: 287, Issue:4 Topics: Adenosine; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Consciousness; Coronary Circulation; Coronary Vessels; Cromakalim; Dobutamine; Dogs; Drug Interactions; Endothelin A Receptor Antagonists; Endothelin-1; Ganglionic Blockers; Nitric Oxide; Oxygen Consumption; Receptor, Endothelin A; Receptors, Adrenergic, beta; Vascular Resistance; Vasodilation; Vasodilator Agents	2004

Article

Year

Pathophysiological plasma ET-1 levels antagonize beta-adrenergic dilation of coronary resistance vessels in conscious dogs.

American journal of physiology. Heart and circulatory physiology, 2004, Volume: 287, Issue:4

Topics: Adenosine; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Consciousness; Coronary Circulation; Coronary Vessels; Cromakalim; Dobutamine; Dogs; Drug Interactions; Endothelin A Receptor Antagonists; Endothelin-1; Ganglionic Blockers; Nitric Oxide; Oxygen Consumption; Receptor, Endothelin A; Receptors, Adrenergic, beta; Vascular Resistance; Vasodilation; Vasodilator Agents

2004